Literature DB >> 7821934

Comparative clinical and electrophysiologic effects of adenosine and verapamil on termination of paroxysmal supraventricular tachycardia.

K K Sethi1, B Singh, G S Kalra, R Arora, M Khalilullah.   

Abstract

The efficacy and electrophysiologic effects of adenosine and verapamil in termination of paroxysmal supraventricular tachycardia (SVT) were compared in 18 patients (age 18-48 years, mean 33 +/- 9 years) with recurrent sustained and inducible SVT. Ten patients had atrioventricular nodal reentrant tachycardia (AVNRT) and 8 had atrioventricular reentrant tachycardia involving a retrograde accessory pathway (cycle length of SVT 280-360 msec; mean 315 +/- 20 msec). Each patient served as his own control. After induction of SVT, adenosine was administered first (6 mg i.v. bolus). If the tachycardia was not terminated, a bolus of 12 mg was given. Ten minutes later, verapamil (5 mg i.v. over 30 sec) was administered after reinduction of SVT. If the tachycardia was not terminated, a 5 mg dose was repeated every 5 minutes upto 20 mg. Adenosine terminated the SVT in 16 cases (6 mg - 7 patients, 12 mg - 9 patients). Verapamil was effective in 11 patients (5 mg - 6 patients, 10 mg - 4 patients, 15 mg - 1 patient, 20 mg - nil). The overall efficacy of adenosine (89%) was significantly greater than that of verapamil (61%; p < 0.05). Adenosine terminated the tachycardia more quickly than verapamil (mean 24 +/- 11 sec versus 142 +/- 40 sec; p < 0.01). Termination of tachycardia by both drugs was related to antegrade block of the atrioventricular node in all patients except one with AVNRT in whom adenosine blocked the retrograde fast pathway. Ventricular premature beats were seen transiently in 5 patients following adenosine. Transient side effects such as flushing, burning and chest pain were frequently observed with adenosine and correlated with the termination of tachycardia.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7821934

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


  3 in total

Review 1.  Adenosine triphosphate: established and potential clinical applications.

Authors:  H J Agteresch; P C Dagnelie; J W van den Berg; J H Wilson
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

Review 2.  Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia.

Authors:  Samer Alabed; Ammar Sabouni; Rui Providencia; Edmond Atallah; Mohammed Qintar; Timothy Ja Chico
Journal:  Cochrane Database Syst Rev       Date:  2017-10-12

3.  Intravenous ATP infusions can be safely administered in the home setting: a study in pre-terminal cancer patients.

Authors:  Sandra Beijer; Eric A R Gielisse; Pierre S Hupperets; Ben E E M van den Borne; Marieke van den Beuken-van Everdingen; Marten R Nijziel; Arjen M J van Henten; Pieter C Dagnelie
Journal:  Invest New Drugs       Date:  2007-09-05       Impact factor: 3.850

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.